药剂师领导的预防复发的塞图西马布输液反应
Yota Yamada1, Arisa Fukuyama1,2, Motoyasu Miyazaki1,2
1Department of Pharmacy, Fukuoka University Chikushi Hospital, Chikushino, JPN.
Cureus
|December 29, 2025
概括
一个由药剂师领导的策略,结合H2受体对抗剂前期治疗和延长输液时间,成功地预防了在患有转移性结直肠癌的高风险患者中,塞图西马布输液反应.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
背景情况:
- 塞图西马布输液反应 (IRs) 可以中断癌症治疗.
- 缺乏标准化的病房级策略来预防反复发生的IR.
研究的目的:
- 描述药剂师主导的干预措施,以预防复发的塞图西马布输液反应.
- 评估结合H2受体对抗剂前期治疗与延长输液时间的安全性和有效性.
主要方法:
- 一个单一的观察,一个患有转移性结直肠癌的高风险患者在塞图西马布输注期间经历了2级IR.
- 实行药剂师建议的捆绑药物:H1抗组胺,静脉注射 famotidine (H2 阻断剂) 和延长 cetuximab 输液时间 (大约2小时). 2小时). 两个小时).
- 在输注期间进行标准化的护理监测.
主要成果:
- 患者接受了随后的塞图西马布输液,没有复发的IR或呼吸道症状.
- 干预成功地管理了一般病房环境中的IR风险.
结论:
- 药剂师驱动的检查清单,包括H2阻塞和长时间输液,可以提高安全性和治疗坚持.
- 这种务实的方法可以减轻IR风险,特别是在无敏化资源有限的地方.
- 需要前性验证来比较单独的H1与组合的H1 + H2前期治疗.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
516
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
516
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
564
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
564
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
162
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
162
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K


